The Limited Times

Now you can see non-English news...

Covid-19: Beijing approves its Sinovac vaccine, the second product in China

2021-02-06T12:07:46.755Z


China had so far formally approved only one of its vaccines at the end of December, developed by the Sinopharm laboratory.


The Chinese drug regulatory authority has given its "conditional" approval for a second vaccine against Covid-19, the CoronaVac from Sinovac, the Chinese pharmaceutical company announced on Saturday.

The vaccine has already been used to vaccinate certain “at risk” populations, but this authorization allows it to be used by the general public.

READ ALSO>

Covid-19: can we trust Russian and Chinese vaccines?


A conditional authorization allows emergency treatments to be deployed on the market, in cases where clinical trials have yet to be continued but already indicate that these treatments will work.

This authorization comes after several trials of the vaccine, in China and in countries such as Brazil and Turkey, although "the results in terms of efficacy and safety have yet to be confirmed," Sinovac said in a statement.

Vaccines "effective and safe", says Beijing

China had so far formally approved only one of its vaccines at the end of December, developed by the Sinopharm laboratory.

According to Sinovac, large-scale testing in Brazil has shown an overall vaccine effectiveness rate of around 50% in preventing infection, and 80% in preventing cases requiring medical intervention.

The move comes as Europe, faced with delays in the delivery of vaccines already ordered, is increasingly tempted to buy Russian and Chinese vaccines.

This Thursday, Beijing also reacted to the words of Emmanuel Macron, who had criticized the opacity around the results of the Chinese vaccine.

At the risk, according to him, that this serum is counterproductive and even leads to "the emergence of new variants".

The communist regime notably affirmed that its vaccines "are effective and safe"

Source: leparis

All life articles on 2021-02-06

You may like

News/Politics 2024-03-16T18:46:42.470Z
News/Politics 2024-03-14T06:43:17.674Z

Trends 24h

Life/Entertain 2024-03-28T17:17:20.523Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.